The vascular access device market was valued at USD 6.02 billion in 2024 and is projected to reach USD 6.49 billion in 2025 and USD 13.65 billion by 2034, advancing at a CAGR of 7.7% during the forecast period 2025–2034. North America held the largest share in 2024. Growth is supported by an aging population, chronic disease prevalence, and adoption of minimally invasive procedures. Competitive participants include B. Braun Melsungen AG, C.R. Bard (acquired by Medtronic), Cook Medical, Terumo Corporation, Smiths Medical, Medtronic, Abbott Laboratories, Teleflex Incorporated, AngioDynamics, Fresenius Medical Care, Johnson & Johnson, ICU Medical, Vygon SA, ConvaTec Group, and Becton, Dickinson and Company.

Infection Prevention Becomes a Core Purchasing Criterion

Infection prevention has become a major focus because of the risks tied to catheter-related bloodstream infections, which can lead to severe complications including sepsis and organ failure. The World Health Organization (WHO) notes that healthcare-associated infections account for about 7% of hospital-acquired conditions worldwide. In response, manufacturers are developing devices with improved materials and designs, and antimicrobial-coated catheters, improved insertion techniques, and contamination-reducing devices are gaining popularity. Providers are also adopting stricter protocols to reduce infection rates. In October 2023, B. Braun launched a new line of antimicrobial-coated catheters designed to reduce the risk of catheter-related bloodstream infections.

Technology and Minimally Invasive Innovation

Demand for less invasive, easier-to-use devices with faster recovery times is driving innovation. New materials, including bioabsorbable and polymer-coated catheters, are improving comfort and effectiveness, while robotic-assisted insertion points to growing automation. Ultrasound-guided catheter insertion is making procedures more accurate and reducing complication risk; a study in The Journal of Vascular Access found that ultrasound-guided procedures have reduced complication rates by up to 50%. In September 2023, Medtronic announced a new ultrasound-guided vascular access device aimed at improving the accuracy and safety of catheter insertion.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/vascular-access-device-market

Short PIVCs Lead Product Demand

By product, short peripheral intravenous catheters (PIVCs) accounted for the largest share in 2024, reflecting widespread use in routine intravenous access, particularly in hospital settings for short-term therapies. They are favored for ease of use, affordability, and minimal complications. Short peripheral intravenous catheters compete within a segment that also includes Huber needles, midline catheters, PICCs, CVCs, dialysis catheters, and implantable ports.

End-User Shifts: Hospitals, ASCs, and the Home

Hospitals hold the largest end-user share as the primary setting for surgeries, chemotherapy, and intensive care. Ambulatory surgery centers register the highest growth, supported by outpatient care preferences for cost-effective, less invasive procedures. Home healthcare vascular access is also gaining ground: patients increasingly favor home treatment for convenience and lower costs, and the CDC reports that over 40% of home health patients require intravenous therapies. Long-term care facilities are seeing gradual increases in VAD use as well. Players are targeting this segment with devices that are effective and easy to use and maintain at home.

Growth Strategies Among Market Players

Growth strategies center on innovation, geographic expansion, and partnerships. Companies are developing safer products such as antimicrobial-coated catheters and ultrasound-guided insertion devices, expanding in Asia Pacific and Latin America where healthcare infrastructure is improving, and using mergers, acquisitions, and partnerships to broaden portfolios. Medtronic’s acquisition of C.R. Bard exemplifies portfolio expansion. A restraint remains: VADs may cause serious complications such as catheter malposition, cardiac perforation, and extravasation.

Outlook for B2B Stakeholders

Asia Pacific is expected to record the highest regional growth, while North America remains the largest market, underpinned by advanced healthcare infrastructure and high healthcare spending. New entrants can compete through catheter-related bloodstream infections prevention, ultrasound-guided catheter insertion tools, and reliable home healthcare vascular access devices  solutions, backed by strong provider relationships and regulatory compliance.

More Trending Latest Reports By Polaris Market Research:

fintech-market

catalyst-market

ashwagandha-extract-market

olive-oil-market

vitamin-k2-market

acrylonitrile-butadiene-styrene-abs-market

reverse-osmosis-membrane-market

supply-chain-management-market

predictive-disease-analytics-market